RILEY BOVE

Allopathic & Osteopathic Physicians|Internal Medicine SAN FRANCISCO, CA NPI 1053516625

General Payments — all program years on this page

$266,859.58

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 185
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $54,115.71 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $49,932.0012
Travel and Lodging $2,998.115
Food and Beverage $1,185.6021

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Merck KGaA $16,250.003
Alexion Pharmaceuticals, Inc. $14,603.7216
TG THERAPEUTICS, INC. $12,051.767
Amgen Inc. $9,105.698
GENZYME CORPORATION $1,929.001
EMD Serono, Inc. $150.212
NOVARTIS PHARMACEUTICALS CORPORATION $25.331

By program year

Program yearAmountRecords
2018 $46,956.5428
2019 $74,027.4460
2020 $29,443.0011
2021 $21,025.338
2022 $23,547.1923
2023 $17,744.3717
2024 $54,115.7138

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086739135 Novartis Pharmaceuticals Corporation $25.33 04/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093892545 Alexion Pharmaceuticals, Inc. $17.50 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093903096 Alexion Pharmaceuticals, Inc. $38.08 07/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093916518 Alexion Pharmaceuticals, Inc. $44.91 07/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093934047 Alexion Pharmaceuticals, Inc. $28.89 07/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093936736 Alexion Pharmaceuticals, Inc. $7,100.00 05/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093942832 Alexion Pharmaceuticals, Inc. $174.65 07/24/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1093943998 Alexion Pharmaceuticals, Inc. $134.60 07/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093944323 Alexion Pharmaceuticals, Inc. $400.00 04/12/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1093946433 Alexion Pharmaceuticals, Inc. $113.14 04/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093963604 Alexion Pharmaceuticals, Inc. $26.93 07/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093977812 Alexion Pharmaceuticals, Inc. $48.19 07/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093981126 Alexion Pharmaceuticals, Inc. $24.09 07/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093981603 Alexion Pharmaceuticals, Inc. $6,390.00 09/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093995454 Alexion Pharmaceuticals, Inc. $20.70 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093995969 Alexion Pharmaceuticals, Inc. $8.02 04/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1094004522 Alexion Pharmaceuticals, Inc. $34.02 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115459365 Amgen Inc. $135.41 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115459368 Amgen Inc. $29.85 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115459372 Amgen Inc. $32.43 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115459376 Amgen Inc. $4,950.00 05/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1115459380 Amgen Inc. $122.56 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115459383 Amgen Inc. $25.00 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115459386 Amgen Inc. $510.44 07/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1115459390 Amgen Inc. $3,300.00 07/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1120255473 EMD Serono, Inc. $30.88 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120274470 EMD Serono, Inc. $119.33 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133237945 Merck KGaA $12,000.00 03/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133237947 Merck KGaA $2,000.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133237949 Merck KGaA $2,250.00 02/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1136887722 TG Therapeutics, Inc. $2,025.00 04/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1136887734 TG Therapeutics, Inc. $1,905.00 05/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1136887738 TG Therapeutics, Inc. $3,600.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1136887778 TG Therapeutics, Inc. $2,700.00 09/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1136887796 TG Therapeutics, Inc. $1,688.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1136887878 TG Therapeutics, Inc. $76.47 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136887886 TG Therapeutics, Inc. $57.29 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139814271 GENZYME CORPORATION $1,929.00 05/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.